Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.

Jin G, Sun J, Liu W, Zhang Z, Chu LW, Kim ST, Sun J, Feng J, Duggan D, Carpten JD, Wiklund F, Grönberg H, Isaacs WB, Zheng SL, Xu J.

Carcinogenesis. 2011 Jul;32(7):1057-62. doi: 10.1093/carcin/bgr082. Epub 2011 May 5.

2.

Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.

Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim ST, Sun J, Wiklund F, Wiley K, Isaacs SD, Stattin P, Xu J, Duggan D, Carpten JD, Isaacs WB, Grönberg H, Zheng SL, Chang BL.

Cancer Res. 2009 Mar 15;69(6):2176-9. doi: 10.1158/0008-5472.CAN-08-3151. Epub 2009 Mar 3.

3.

Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.

Xie CC, Lu L, Sun J, Zheng SL, Isaacs WB, Gronberg H, Xu J.

J Hum Genet. 2011 Jul;56(7):496-502. doi: 10.1038/jhg.2011.48. Epub 2011 Jun 2.

4.

A novel prostate cancer susceptibility locus at 19q13.

Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, Purcell LD, Gao Z, Stattin P, Zhu Y, Kim ST, Zhang Z, Liu W, Chang BL, Walsh PC, Duggan D, Carpten JD, Isaacs WB, Grönberg H, Xu J, Zheng SL.

Cancer Res. 2009 Apr 1;69(7):2720-3. doi: 10.1158/0008-5472.CAN-08-3347. Epub 2009 Mar 24.

5.

Sequence variants at 22q13 are associated with prostate cancer risk.

Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Stattin P, Liu W, Kim JW, Duggan D, Carpten J, Isaacs W, Grönberg H, Xu J, Chang BL.

Cancer Res. 2009 Jan 1;69(1):10-5. doi: 10.1158/0008-5472.CAN-08-3464.

6.

A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.

Feng J, Sun J, Kim ST, Lu Y, Wang Z, Zhang Z, Gronberg H, Isaacs WB, Zheng SL, Xu J.

Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2396-403. doi: 10.1158/1055-9965.EPI-11-0523. Epub 2011 Sep 29.

7.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
8.

Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness.

Wu D, Yu H, Sun J, Qi J, Liu Q, Li R, Zheng SL, Xu J, Kang J.

Mol Med Rep. 2015 Jul;12(1):489-97. doi: 10.3892/mmr.2015.3410. Epub 2015 Mar 4.

PMID:
25738283
9.

A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.

Tao S, Wang Z, Feng J, Hsu FC, Jin G, Kim ST, Zhang Z, Gronberg H, Zheng LS, Isaacs WB, Xu J, Sun J.

Carcinogenesis. 2012 Mar;33(3):598-603. doi: 10.1093/carcin/bgr316. Epub 2012 Jan 4.

10.

Validation of copy number variants associated with prostate cancer risk and prognosis.

Blackburn A, Wilson D, Gelfond J, Yao L, Hernandez J, Thompson IM, Leach RJ, Lehman DM.

Urol Oncol. 2014 Jan;32(1):44.e15-44.e20. doi: 10.1016/j.urolonc.2013.06.004. Epub 2013 Sep 17.

11.

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.

Sun J, Chang BL, Isaacs SD, Wiley KE, Wiklund F, Stattin P, Duggan D, Carpten JD, Trock BJ, Partin AW, Walsh PC, Grönberg H, Xu J, Isaacs WB, Zheng SL.

Prostate. 2008 Sep 1;68(12):1257-62. doi: 10.1002/pros.20793.

12.

Genome-wide two-locus epistasis scans in prostate cancer using two European populations.

Tao S, Feng J, Webster T, Jin G, Hsu FC, Chen SH, Kim ST, Wang Z, Zhang Z, Zheng SL, Isaacs WB, Xu J, Sun J.

Hum Genet. 2012 Jul;131(7):1225-34. doi: 10.1007/s00439-012-1148-4. Epub 2012 Feb 26.

13.

Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.

Chen YC, Giovannucci E, Kraft P, J Hunter D.

Carcinogenesis. 2008 May;29(5):999-1004. doi: 10.1093/carcin/bgn081. Epub 2008 Mar 28.

14.

Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.

Cussenot O, Azzouzi AR, Bantsimba-Malanda G, Gaffory C, Mangin P, Cormier L, Fournier G, Valeri A, Jouffe L, Roupret M, Fromont G, Sibony M, Comperat E, Cancel-Tassin G.

Clin Cancer Res. 2008 Sep 1;14(17):5635-9. doi: 10.1158/1078-0432.CCR-07-4999.

15.

Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men.

Beuten J, Gelfond JA, Martinez-Fierro ML, Weldon KS, Crandall AC, Rojas-Martinez A, Thompson IM, Leach RJ.

Carcinogenesis. 2009 Aug;30(8):1372-9. doi: 10.1093/carcin/bgp148. Epub 2009 Jun 15.

16.

Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.

Lu Y, Sun J, Kader AK, Kim ST, Kim JW, Liu W, Sun J, Lu D, Feng J, Zhu Y, Jin T, Zhang Z, Dimitrov L, Lowey J, Campbell K, Suh E, Duggan D, Carpten J, Trent JM, Gronberg H, Zheng SL, Isaacs WB, Xu J.

Prostate. 2012 Mar;72(4):376-85. doi: 10.1002/pros.21439. Epub 2011 Jun 10.

17.

IL-10 polymorphisms and prostate cancer risk: a meta-analysis.

Shao N, Xu B, Mi YY, Hua LX.

Prostate Cancer Prostatic Dis. 2011 Jun;14(2):129-35. doi: 10.1038/pcan.2011.6. Epub 2011 Feb 22.

PMID:
21339768
18.

Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.

Lindström S, Wiklund F, Jonsson BA, Adami HO, Bälter K, Brookes AJ, Xu J, Zheng SL, Isaacs WB, Adolfsson J, Grönberg H.

Hum Genet. 2005 Dec;118(3-4):339-47. Epub 2005 Sep 28.

PMID:
16189707
19.

Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.

Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L.

Cytokine. 2006 Jul;35(1-2):21-8. Epub 2006 Sep 5. Erratum in: Cytokine. 2006 Nov;36(3-4):199-200.

PMID:
16908180
20.

Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.

Pierce BL, Ahsan H.

Hum Hered. 2010;69(3):193-201. doi: 10.1159/000289594. Epub 2010 Mar 5.

Supplemental Content

Support Center